Salts and Derivatives of Active Pharmaceutical Ingredients (API)

The salts of Active Pharmaceutical Ingredients (APIs) are compounds formed by the reaction of an acid with a base, resulting in an ionic equilibrium. These salts often improve the solubility and stability of APIs, facilitating their absorption in the body. API derivatives are chemical variants of an active ingredient that may have enhanced or modified properties to optimise therapeutic efficacy. API salts are used in the formulation of oral, injectable, and topical medications. Additionally, API derivatives can improve the pharmacokinetics of drugs, such as enabling controlled release of active substances. At CymitQuimica, we provide API salts and derivatives with the necessary purity and quality for research and pharmaceutical formulation development.

Found 79473 products of "Salts and Derivatives of Active Pharmaceutical Ingredients (API)"

Purity (%)

100

products per page.

+ Info
Leflunomide Related Compound B (Z)-2-cyano-3-hydroxy-N-(4-(trifluoromethyl)phenyl)but-2-enamide
CAS:
- 163451-81-8
Nitrile function compounds, not elsewhere specified or included
Formula:C₁₂H₉F₃N₂O₂
Color and Shape:White Off-White Powder
Molecular weight:270.06161
Ref: 45-1357056
+ Info
Allopurinol Related Compound F (ethyl-(E/Z)-3-(2-carbethoxy-2-cyanoethenyl)amino-1H-pyrazole-4-carboxylate)
CAS:
- 321571-07-7
Compounds containing an unfused pyrazole ring, whether or not hydrogenated, in the structure, nesoi
Formula:C₁₂H₁₄N₄O₄
Color and Shape:Powder
Molecular weight:278.1015
Ref: 45-1013079
+ Info
Dofetilide Related Compound D (4-{2-[(4-Aminophenethyl)(methyl)amino]ethoxy}aniline)
CAS:
- 115256-13-8
Amino-naphthols and other amino-phenols, their ethers and esters, other than those cont more than one kind of oxygen function; salts thereof, nesoi
Formula:C₁₇H₂₃N₃O
Color and Shape:Off-White Powder
Molecular weight:285.18411
Ref: 45-1225044
+ Info
Terbinafine Related Compound B ((2Z)-N,6,6-Trimethyl-N-(naphthalen-1-ylmethyl)hept-2-en-4-yn-1-amine hydrochloride)
CAS:
- 176168-78-8
Aromatic monoamines not elsewhere specified or included
Formula:C₂₁H₂₅N·HCl
Color and Shape:Off-White Powder
Molecular weight:291.1987
Ref: 45-1643532
+ Info
Dofetilide Related Compound B (N-Methyl-N-[4-(methylsulfonamido)phenethyl]-2-[4-(methylsulfonamido)phenoxy]ethan-1-amine oxide)
CAS:
- 144449-71-8
Sulfonamides, nesoi
Formula:C₁₉H₂₇N₃O₆S₂
Color and Shape:Off-White Powder
Molecular weight:457.13413
Ref: 45-1225011
+ Info
Tinidazole Related Compound A (2-methyl-5-nitroimidazole)
CAS:
- 696-23-1
Compounds containing an unfused imidazole ring (whether or not hydrogenated) in the structure nesoi
Formula:C₄H₅N₃O₂
Color and Shape:Off-White Powder
Molecular weight:127.03818
Ref: 45-1667530
+ Info
Vecuronium Bromide Related Compound B (Piperidinium, 1-[(2β, 3α, 5α, 16β, 17β)-3-acetyloxy-17-hydroxy-2-(1-piperidinyl)androstan-16-yl]-1-methyl bromide)
CAS:
- 50587-95-6
Compounds containing an unfused pyridine ring in the structure, nesoi
Formula:C₃₂H₅₅BrN₂O₃
Color and Shape:Off-White Powder
Molecular weight:594.33961
Ref: 45-1711177
+ Info
Dapagliflozin Related Compound A ((2S,3R,4R,5S,6R)-2-[4-Bromo-3-(4-ethoxybenzyl)phenyl]-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol)
CAS:
- 1807632-95-6
Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoi
Formula:C₂₁H₂₅BrO₆
Color and Shape:White Solid
Molecular weight:453.33 g/mol
Ref: 45-1163264
+ Info
Topotecan Related Compound A ((S)-10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-8-methoxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione)
CAS:
- 3077786-35-4
Other alkaloids,natural or reproduced by synthesis, and their salts, ethers,esters&other derivatives, nesoi
Formula:C₂₄H₂₅N₃O₆
Color and Shape:Solid
Molecular weight:451.17434
Ref: 45-1672268
+ Info
Hexyl Methanesulfonate
CAS:
- 16156-50-6
Hydrocarbon derivatives containing only sulfo groups, their salts andesters
Formula:C₇H₁₆O₃S
Color and Shape:Clear Yellow Liquid
Molecular weight:180.08202
Ref: 45-1162273
+ Info
Ciclopirox Related Compound A (3-Cyclohexyl-4,5-dihydro-5-methyl-5-isoxazolyl acetic acid)
Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoi
Formula:C₁₂H₁₉NO₃
Color and Shape:White Powder
Molecular weight:225.29
Ref: 45-1134029
+ Info
Nebivolol Related Compound E (1-(Chroman-2-yl)-2-((2-(6-fluorochroman-2-yl)-2-hydroxyethyl)amino)ethanol hydrochloride)
Aromatic pesticides with oxygen hetero
Formula:C₂₂H₂₆FNO₄·HCl
Color and Shape:Powder
Molecular weight:423.16126
Ref: 45-1457899
+ Info
Propofol Related Compound B (2,6-Diisopropyl-1,4-benzoquinone)
CAS:
- 1988-11-0
Other quinones
Formula:C₁₂H₁₆O₂
Color and Shape:Yellow Liquid
Molecular weight:192.11503
Ref: 45-1572547
+ Info
6,7-Dehydronorethindrone Acetate (3-oxo-19-nor-17α-pregn-4,6-dien-20-yn-17-yl acetate)
CAS:
- 106765-04-2
Carboxylic acids with aldehyde or ketone function but without other oxygen function, their anhydrides, halides, peroxides, peroxyacids andtheir deriv
Formula:C₂₂H₂₆O₃
Color and Shape:White Powder
Molecular weight:338.18819
Ref: 45-1166535
+ Info
Norfloxacin Related Compound K (6-Fluoro-1-methyl-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid)
CAS:
- 70459-07-3
Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoi
Formula:C₁₅H₁₆FN₃O₃
Color and Shape:Off-White Solid
Molecular weight:305.3
Ref: 45-1471619
+ Info
Allopurinol Related Compound E (Ethyl 5-(formylamino)-1H-pyrazole-4-carboxylate)
CAS:
- 31055-19-3
Compounds containing an unfused pyrazole ring, whether or not hydrogenated, in the structure, nesoi
Formula:C₇H₉N₃O₃
Color and Shape:White Off-White Powder
Molecular weight:183.16 g/mol
Ref: 45-1013068
+ Info
(R)-Clopidogrel Carboxylic Acid ((R)-2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetic acid)
CAS:
- 324757-50-8
Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoi
Formula:C₁₅H₁₄ClNO₂S
Color and Shape:Off-White Solid
Molecular weight:307.79
Ref: 45-1A00550
+ Info
Sibutramine Related Compound A (N-{1-[1-(2-chlorophenyl)cyclobutyl]-3-methylbutyl}-N,N-dimethylamine hydrochloride)
Aromatic monoamines not elsewhere specified or included
Formula:C₁₇H₂₆ClN·HCl·H₂O
Color and Shape:White Crystalline Powder
Molecular weight:334.3
Ref: 45-1612856
+ Info
Anagrelide Related Compound A (ethyl 2-(6-amino-2,3-dichlorobenzylamino)acetate)
CAS:
- 85325-12-8
Aromatic amino-acids and their esters, other than those containing more than one kind of oxygen function, nesoi
Formula:C₁₁H₁₄Cl₂N₂O₂·HCl
Color and Shape:Off-White Powder
Molecular weight:276.04323
Ref: 45-1034749
+ Info
Moexipril Related Compound D ((S)-2-{(S)-2-[(S)-4-cyclohexyl-1-ethoxy-1-oxobutan-2-ylamino]propanoyl}-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid hydrochloride)
CAS:
- 1356019-89-0
Compounds containing a quinoline or isoquinoline ring-system, whether or not hydrogenated, not further fused, excluding drugs and pesticides
Formula:C₂₇H₄₀N₂O₇·HCl
Color and Shape:Beige Powder
Molecular weight:504.28355
Ref: 45-1445631

Salts and Derivatives of Active Pharmaceutical Ingredients (API)

Found 79473 products of "Salts and Derivatives of Active Pharmaceutical Ingredients (API)"

Leflunomide Related Compound B (Z)-2-cyano-3-hydroxy-N-(4-(trifluoromethyl)phenyl)but-2-enamide

Ref: 45-1357056

Allopurinol Related Compound F (ethyl-(E/Z)-3-(2-carbethoxy-2-cyanoethenyl)amino-1H-pyrazole-4-carboxylate)

Ref: 45-1013079

Dofetilide Related Compound D (4-{2-[(4-Aminophenethyl)(methyl)amino]ethoxy}aniline)

Ref: 45-1225044

Terbinafine Related Compound B ((2Z)-N,6,6-Trimethyl-N-(naphthalen-1-ylmethyl)hept-2-en-4-yn-1-amine hydrochloride)

Ref: 45-1643532

Dofetilide Related Compound B (N-Methyl-N-[4-(methylsulfonamido)phenethyl]-2-[4-(methylsulfonamido)phenoxy]ethan-1-amine oxide)

Ref: 45-1225011

Tinidazole Related Compound A (2-methyl-5-nitroimidazole)

Ref: 45-1667530

Vecuronium Bromide Related Compound B (Piperidinium, 1-[(2β, 3α, 5α, 16β, 17β)-3-acetyloxy-17-hydroxy-2-(1-piperidinyl)androstan-16-yl]-1-methyl bromide)

Ref: 45-1711177

Dapagliflozin Related Compound A ((2S,3R,4R,5S,6R)-2-[4-Bromo-3-(4-ethoxybenzyl)phenyl]-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol)

Ref: 45-1163264

Topotecan Related Compound A ((S)-10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-8-methoxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione)

Ref: 45-1672268

Hexyl Methanesulfonate

Ref: 45-1162273

Ciclopirox Related Compound A (3-Cyclohexyl-4,5-dihydro-5-methyl-5-isoxazolyl acetic acid)

Ref: 45-1134029

Nebivolol Related Compound E (1-(Chroman-2-yl)-2-((2-(6-fluorochroman-2-yl)-2-hydroxyethyl)amino)ethanol hydrochloride)

Ref: 45-1457899

Propofol Related Compound B (2,6-Diisopropyl-1,4-benzoquinone)

Ref: 45-1572547

6,7-Dehydronorethindrone Acetate (3-oxo-19-nor-17α-pregn-4,6-dien-20-yn-17-yl acetate)

Ref: 45-1166535

Norfloxacin Related Compound K (6-Fluoro-1-methyl-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid)

Ref: 45-1471619

Allopurinol Related Compound E (Ethyl 5-(formylamino)-1H-pyrazole-4-carboxylate)

Ref: 45-1013068

(R)-Clopidogrel Carboxylic Acid ((R)-2-(2-chlorophenyl)-2-(6,7-dihydrothieno[3,2-c]pyridin-5(4H)-yl)acetic acid)

Ref: 45-1A00550

Sibutramine Related Compound A (N-{1-[1-(2-chlorophenyl)cyclobutyl]-3-methylbutyl}-N,N-dimethylamine hydrochloride)

Ref: 45-1612856

Anagrelide Related Compound A (ethyl 2-(6-amino-2,3-dichlorobenzylamino)acetate)

Ref: 45-1034749

Moexipril Related Compound D ((S)-2-{(S)-2-[(S)-4-cyclohexyl-1-ethoxy-1-oxobutan-2-ylamino]propanoyl}-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid hydrochloride)

Ref: 45-1445631